Green Brick Partners (GRBK) Prices 850K Share Secondary Offering at $45.75/sh

Green Brick Partners, Inc. (NYSE: GRBK) (“Green Brick,” or the “Company”), a leading national homebuilder and land development company, today announced the pricing of a secondary offering of 850,000 shares of its common stock held by an investment fund, at a public offering price of $45.75 per share (the “Offering”). An affiliate of Greenlight Capital, Inc. serves as an investment adviser to the investment fund and may be deemed to beneficially own the shares being sold. Green Brick did not offer any shares of its common stock and will not receive any of the proceeds from the sale of the shares in the Offering. The Offering is expected to close on September 8, 2023, subject to the satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC is acting as the book-running manager for the Offering.

The Offering is being made pursuant to an automatically effective shelf registration statement on Form S-3 filed with the Securities Exchange Commission (the “SEC”) on September 6, 2023 and only by means of a prospectus and prospectus supplement. A copy of the final prospectus supplement and the accompanying prospectus relating to this Offering, when available, may be obtained by visiting the SEC website at www.sec.gov or by contacting: Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, New York 10282, by telephone at 1-866-471-2526 or by emailing [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

You May Also Be Interested In

• Chewy stock falls as meme stock influencer Roaring Kitty reveals 6.6% stake
• Arcturus Therapeutics (ARCT) Provides Updates for Ornithine Transcarbamylase (OTC) Deficiency and Cystic Fibrosis (CF) Programs
• Masimo Corp. (MASI) Issues Response to "Latest Politan Fictions"